← Back to Clinical Trials
Recruiting NCT07696598

NCT07696598 Extradural Hematoma in Pediatrics After Acute Head Injury: Surgical and Clinical Outcome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07696598
Status Recruiting
Phase
Sponsor Sohag University
Condition Pediatric Traumatic Brain Injury
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-06-20
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 1 Day
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
evacuation of hematoma

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-06-20 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Acute extradural hematoma (EDH) is a potentially life-threatening neurosurgical emergency in children, commonly resulting from traumatic head injury. Early diagnosis and timely surgical intervention are critical factors influencing neurological recovery and overall outcome. Despite advances in neuroimaging and surgical techniques, the clinical presentation, management strategies, and outcomes of pediatric EDH remain variable

Eligibility Criteria

Inclusion Criteria: * Pediatric patients (\<18 years of age). * Patients with traumatic extradural (epidural) hematoma. * Patients who underwent surgical evacuation of the extradural hematoma. Exclusion Criteria: * Patients with coagulopathy. * Patients with autoimmune disorders. * Patients with a previous operation for extradural hematoma. * Patients with associated intracranial hematomas (e.g., subdural hematoma, subarachnoid hemorrhage, or brain contusion). * Patients with panfacial fractures. * Patients with significant general surgical, cardiothoracic, or orthopedic comorbidit.

Contact & Investigator

Central Contact

abdelrahman mohamed neurosurgery department of sohag university, resident

✉ abduabdelaala@gmail.com

📞 01021293440

Frequently Asked Questions

Who can join the NCT07696598 clinical trial?

This trial is open to participants of all sexes, aged 1 Day or older, up to 18 Years, studying Pediatric Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07696598 currently recruiting?

Yes, NCT07696598 is actively recruiting participants. Contact the research team at abduabdelaala@gmail.com for enrollment information.

Where is the NCT07696598 trial being conducted?

This trial is being conducted at Sohag, Egypt.

Who is sponsoring the NCT07696598 clinical trial?

NCT07696598 is sponsored by Sohag University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology